A 0 8 (Mirtazapine 15 mg)
Pill imprint A 0 8 has been identified as Mirtazapine 15 mg.
Mirtazapine is used in the treatment of insomnia; major depressive disorder; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- A 0 8
- Strength:
- 15 mg
- Color:
- Yellow
- Size:
- 9.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0031
- Inactive Ingredients:
- corn starch
low substituted hydroxypropyl cellulose
magnesium stearate
silicon dioxide
lactose monohydrate
hypromellose 2910 (6 mPa.s)
titanium dioxide
hydroxypropyl cellulose
ferric oxide yellow
| NDC Code | Manufacturer / Repackager |
|---|---|
| 13107-0031 | Aurobindo Pharma Limited |
| 59762-1416 | Greenstone LLC |
| 68084-0119 | Amerisource Health Services |
Note: Inactive ingredients may vary.
More about mirtazapine
Consumer resources
- Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
